Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Usmani, Saad

One or more keywords matched the following items that are connected to Usmani, Saad

Item Type	Name
Concept	Immunotherapy, Adoptive
Academic Article	CAR T-cell therapy for multiple myeloma: state of the art and prospects.
Academic Article	Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Academic Article	Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Academic Article	Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Academic Article	Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.
Academic Article	BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy.
Academic Article	Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Academic Article	Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
Academic Article	GPRC5D-Targeted CAR T Cells for Myeloma.
Academic Article	Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy.
Academic Article	How Old is Too Old for CAR-T Cell Therapies in Multiple Myeloma?
Academic Article	The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies.
Academic Article	Cilta-cel, a BCMA-targeting CAR-T therapy for heavily pretreated patients with relapsed/refractory multiple myeloma.
Academic Article	Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies.
Academic Article	Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma.
Academic Article	Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.
Academic Article	ASTCT Committee on Practice Guidelines Survey on Evaluation and Management of Relapsed/Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T Cell Therapy.
Academic Article	Consensus guidelines and recommendations for the management and response assessment of chimeric antigen receptor T-cell therapy in clinical practice for relapsed and refractory multiple myeloma: a report from the International Myeloma Working Group Immunotherapy Committee.
Academic Article	Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.
Academic Article	Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4.

Search Criteria

Immunotherapy Adoptive